Enteryx (TM): for the treatment of gastro-oesophageal reflux disease
Parrella, A
Record ID 32006000628
English
Authors' results and conclusions:
There is limited, low quality (level IV evidence) information available regarding the safety and effectiveness of Enteryx in treating gastro-oesophageal reflux disease (GERD) in the long term. However, the prevalence of GERD in Australia and the cost of treating it is high.
Authors' recommendations:
In light of the evidence and the ongoing controlled investigations of the Enteryx implant, it is recommended that a full health technology assessment be conducted.
Details
Project Status:
Completed
Year Published:
2004
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Prosthesis Implantation
- Gastroesophageal Reflux
- Gastroscopy
- Polyvinyls
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.